Name
News Organization
Phone
Email Address
Message
4 + 8 =
Integrity Laboratories began testing for SARS-CoV-2 (COVID-19) under Emergency Use Authorization (EUA) on March 23.
Please direct all inquiries to covid19@integritylaboratories.com for immediate review.
FDA Authorization Letter | FDA EUA Summary
CARES Act Statement
